BioCentury
ARTICLE | Company News

Graffinity Pharmaceuticals AG, Serono SA deal

April 7, 2003 7:00 AM UTC

Graffinity will use its Rapid Affinity Instructed Structure Evolution (RAISE) technology and drug-fragment chemical microarrays to identify small molecules against five protein targets supplied by SEO...